Vetmab Biosciences
PrivateLast Round
Early Funding
Apr 9, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Vetmab Biosciences is a biotechnology company that develops monoclonal antibody therapeutics for dogs and cats.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vetmab Biosciences Comparables
Compare Vetmab Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vetigenics Inc. | 83% | |
| Dechra Pharmaceuticals Limited | 77% | |
| Ceva Santé Animale | 77% |
Vetmab Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Apr 9, 2025 |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 18, 2026
Monthly visitors increased 47% MoM.
- Apr 15, 2026
Monthly visitors grew 49% MoM, from 640 to 954.
Vetmab Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Vetmab Biosciences's valuation, stock price, and market status.
Is Vetmab Biosciences a public or private company?
Vetmab Biosciences is a private company.
What is the current stock price of Vetmab Biosciences?
Vetmab Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is Vetmab Biosciences worth (valuation)?
Valuation information for Vetmab Biosciences is not publicly available.
Can I buy Vetmab Biosciences stock?
Vetmab Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Vetmab Biosciences's last funding round?
Vetmab Biosciences's most recent funding round was Early Funding on April 9, 2025.
Who are the main investors in Vetmab Biosciences?
Investor information for Vetmab Biosciences is not publicly disclosed.
Will Vetmab Biosciences IPO soon?
No public IPO plans have been announced for Vetmab Biosciences.
How can I track Vetmab Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Vetmab Biosciences's secondary market activity and sign up for updates.